Loading…
microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer
microRNAs (miRNAs) are small, non-coding RNAs of endogenous origin. They have been increasingly shown to have aberrant expression in a number of tumor types. miR-192, -194 and -215 have not been comprehensively investigated using a large number of cases in colorectal cancer (CRC). We extracted total...
Saved in:
Published in: | Experimental and therapeutic medicine 2012-03, Vol.3 (3), p.560-566 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113 |
---|---|
cites | cdi_FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113 |
container_end_page | 566 |
container_issue | 3 |
container_start_page | 560 |
container_title | Experimental and therapeutic medicine |
container_volume | 3 |
creator | CHIANG, YEUNPO SONG, YONGXI WANG, ZHENNING LIU, ZHUANGKAI GAO, PENG LIANG, JIWANG ZHU, JINLIANG XING, CHENGZHONG XU, HUIMIAN |
description | microRNAs (miRNAs) are small, non-coding RNAs of endogenous origin. They have been increasingly shown to have aberrant expression in a number of tumor types. miR-192, -194 and -215 have not been comprehensively investigated using a large number of cases in colorectal cancer (CRC). We extracted total RNA from 107 CRC tissues and three CRC cell lines. Following polyadenylation and reverse transcription, the expression levels of miR-192, -194 and -215 were determined for evaluation of the association between expression levels and clinicopathological characteristics by a quantitative real-time polymerase chain reaction (real-time PCR) method. Finally, we studied the impact of miR-194 on cell proliferation in HCT-116 cells by MTT assay. miR-192, -194 and -215 were significantly downregulated in CRC tissues (all p |
doi_str_mv | 10.3892/etm.2011.436 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3438543</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22969930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113</originalsourceid><addsrcrecordid>eNpVkEtLAzEURoMoVmp3riU7N52a9yQboRRfUBVE1yGTRx2ZR81Mlf57U1uLhpAEcvLl3gPAGUYTKhW59H09IQjjCaPiAJzgXJEMI8wPd2ekJB6AUde9ozS4wFLyYzAgRAmlKDoBD3VpY_v8OM2wImOYVgZN42BGMIcmehii_1j5pq_W0LVfTfSLVWV672DZQNtWbfS2NxW0prE-noKjYKrOj3b7ELzeXL_M7rL50-39bDrPLJOkz2QgMhXDBUN5UJ4LJEXIMaWsQBQ5woNiIQ_SYlQgIYSVIneFdZI77xTGdAiutrnLVVF7Z1N90VR6GcvaxLVuTan_3zTlm160n5oyKjmjKWC8DUjNd130Yf8WI70xq5NZvTGrk9mEn__9bw__ekzAxRbolsle6dpuz6SgDNGfmRql35rEf3M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer</title><source>PubMed Central</source><creator>CHIANG, YEUNPO ; SONG, YONGXI ; WANG, ZHENNING ; LIU, ZHUANGKAI ; GAO, PENG ; LIANG, JIWANG ; ZHU, JINLIANG ; XING, CHENGZHONG ; XU, HUIMIAN</creator><creatorcontrib>CHIANG, YEUNPO ; SONG, YONGXI ; WANG, ZHENNING ; LIU, ZHUANGKAI ; GAO, PENG ; LIANG, JIWANG ; ZHU, JINLIANG ; XING, CHENGZHONG ; XU, HUIMIAN</creatorcontrib><description>microRNAs (miRNAs) are small, non-coding RNAs of endogenous origin. They have been increasingly shown to have aberrant expression in a number of tumor types. miR-192, -194 and -215 have not been comprehensively investigated using a large number of cases in colorectal cancer (CRC). We extracted total RNA from 107 CRC tissues and three CRC cell lines. Following polyadenylation and reverse transcription, the expression levels of miR-192, -194 and -215 were determined for evaluation of the association between expression levels and clinicopathological characteristics by a quantitative real-time polymerase chain reaction (real-time PCR) method. Finally, we studied the impact of miR-194 on cell proliferation in HCT-116 cells by MTT assay. miR-192, -194 and -215 were significantly downregulated in CRC tissues (all p<0.001, paired t-test) and cancer cell lines (all p<0.05) compared to non-tumor counterparts. Moreover, the expression levels of miR-192, -194 and -215 were demonstrated to be associated with increased tumor sizes (p=0.027, p=0.018, and p=0.027, respectively; Mann-Whitney U test). Also, there were marked correlations among these miRNAs in CRC tissues (all p<0.001, Pearson's regression analysis). Furthermore, we found that the overexpression of miR-194 could significantly inhibit cell proliferation in HTC-116 cells. miR-192, -194 and -215 may be important biological markers as tumor suppressors in the carcinogenesis of CRC.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2011.436</identifier><identifier>PMID: 22969930</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>colorectal cancer ; microRNA ; miR-192 ; miR-194 ; miR-215</subject><ispartof>Experimental and therapeutic medicine, 2012-03, Vol.3 (3), p.560-566</ispartof><rights>Copyright © 2012, Spandidos Publications</rights><rights>Copyright © 2012, Spandidos Publications 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113</citedby><cites>FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438543/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438543/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22969930$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHIANG, YEUNPO</creatorcontrib><creatorcontrib>SONG, YONGXI</creatorcontrib><creatorcontrib>WANG, ZHENNING</creatorcontrib><creatorcontrib>LIU, ZHUANGKAI</creatorcontrib><creatorcontrib>GAO, PENG</creatorcontrib><creatorcontrib>LIANG, JIWANG</creatorcontrib><creatorcontrib>ZHU, JINLIANG</creatorcontrib><creatorcontrib>XING, CHENGZHONG</creatorcontrib><creatorcontrib>XU, HUIMIAN</creatorcontrib><title>microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>microRNAs (miRNAs) are small, non-coding RNAs of endogenous origin. They have been increasingly shown to have aberrant expression in a number of tumor types. miR-192, -194 and -215 have not been comprehensively investigated using a large number of cases in colorectal cancer (CRC). We extracted total RNA from 107 CRC tissues and three CRC cell lines. Following polyadenylation and reverse transcription, the expression levels of miR-192, -194 and -215 were determined for evaluation of the association between expression levels and clinicopathological characteristics by a quantitative real-time polymerase chain reaction (real-time PCR) method. Finally, we studied the impact of miR-194 on cell proliferation in HCT-116 cells by MTT assay. miR-192, -194 and -215 were significantly downregulated in CRC tissues (all p<0.001, paired t-test) and cancer cell lines (all p<0.05) compared to non-tumor counterparts. Moreover, the expression levels of miR-192, -194 and -215 were demonstrated to be associated with increased tumor sizes (p=0.027, p=0.018, and p=0.027, respectively; Mann-Whitney U test). Also, there were marked correlations among these miRNAs in CRC tissues (all p<0.001, Pearson's regression analysis). Furthermore, we found that the overexpression of miR-194 could significantly inhibit cell proliferation in HTC-116 cells. miR-192, -194 and -215 may be important biological markers as tumor suppressors in the carcinogenesis of CRC.</description><subject>colorectal cancer</subject><subject>microRNA</subject><subject>miR-192</subject><subject>miR-194</subject><subject>miR-215</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEURoMoVmp3riU7N52a9yQboRRfUBVE1yGTRx2ZR81Mlf57U1uLhpAEcvLl3gPAGUYTKhW59H09IQjjCaPiAJzgXJEMI8wPd2ekJB6AUde9ozS4wFLyYzAgRAmlKDoBD3VpY_v8OM2wImOYVgZN42BGMIcmehii_1j5pq_W0LVfTfSLVWV672DZQNtWbfS2NxW0prE-noKjYKrOj3b7ELzeXL_M7rL50-39bDrPLJOkz2QgMhXDBUN5UJ4LJEXIMaWsQBQ5woNiIQ_SYlQgIYSVIneFdZI77xTGdAiutrnLVVF7Z1N90VR6GcvaxLVuTan_3zTlm160n5oyKjmjKWC8DUjNd130Yf8WI70xq5NZvTGrk9mEn__9bw__ekzAxRbolsle6dpuz6SgDNGfmRql35rEf3M</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>CHIANG, YEUNPO</creator><creator>SONG, YONGXI</creator><creator>WANG, ZHENNING</creator><creator>LIU, ZHUANGKAI</creator><creator>GAO, PENG</creator><creator>LIANG, JIWANG</creator><creator>ZHU, JINLIANG</creator><creator>XING, CHENGZHONG</creator><creator>XU, HUIMIAN</creator><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120301</creationdate><title>microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer</title><author>CHIANG, YEUNPO ; SONG, YONGXI ; WANG, ZHENNING ; LIU, ZHUANGKAI ; GAO, PENG ; LIANG, JIWANG ; ZHU, JINLIANG ; XING, CHENGZHONG ; XU, HUIMIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>colorectal cancer</topic><topic>microRNA</topic><topic>miR-192</topic><topic>miR-194</topic><topic>miR-215</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHIANG, YEUNPO</creatorcontrib><creatorcontrib>SONG, YONGXI</creatorcontrib><creatorcontrib>WANG, ZHENNING</creatorcontrib><creatorcontrib>LIU, ZHUANGKAI</creatorcontrib><creatorcontrib>GAO, PENG</creatorcontrib><creatorcontrib>LIANG, JIWANG</creatorcontrib><creatorcontrib>ZHU, JINLIANG</creatorcontrib><creatorcontrib>XING, CHENGZHONG</creatorcontrib><creatorcontrib>XU, HUIMIAN</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHIANG, YEUNPO</au><au>SONG, YONGXI</au><au>WANG, ZHENNING</au><au>LIU, ZHUANGKAI</au><au>GAO, PENG</au><au>LIANG, JIWANG</au><au>ZHU, JINLIANG</au><au>XING, CHENGZHONG</au><au>XU, HUIMIAN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>3</volume><issue>3</issue><spage>560</spage><epage>566</epage><pages>560-566</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>microRNAs (miRNAs) are small, non-coding RNAs of endogenous origin. They have been increasingly shown to have aberrant expression in a number of tumor types. miR-192, -194 and -215 have not been comprehensively investigated using a large number of cases in colorectal cancer (CRC). We extracted total RNA from 107 CRC tissues and three CRC cell lines. Following polyadenylation and reverse transcription, the expression levels of miR-192, -194 and -215 were determined for evaluation of the association between expression levels and clinicopathological characteristics by a quantitative real-time polymerase chain reaction (real-time PCR) method. Finally, we studied the impact of miR-194 on cell proliferation in HCT-116 cells by MTT assay. miR-192, -194 and -215 were significantly downregulated in CRC tissues (all p<0.001, paired t-test) and cancer cell lines (all p<0.05) compared to non-tumor counterparts. Moreover, the expression levels of miR-192, -194 and -215 were demonstrated to be associated with increased tumor sizes (p=0.027, p=0.018, and p=0.027, respectively; Mann-Whitney U test). Also, there were marked correlations among these miRNAs in CRC tissues (all p<0.001, Pearson's regression analysis). Furthermore, we found that the overexpression of miR-194 could significantly inhibit cell proliferation in HTC-116 cells. miR-192, -194 and -215 may be important biological markers as tumor suppressors in the carcinogenesis of CRC.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>22969930</pmid><doi>10.3892/etm.2011.436</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-0981 |
ispartof | Experimental and therapeutic medicine, 2012-03, Vol.3 (3), p.560-566 |
issn | 1792-0981 1792-1015 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3438543 |
source | PubMed Central |
subjects | colorectal cancer microRNA miR-192 miR-194 miR-215 |
title | microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A15%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=microRNA-192,%20-194%20and%20-215%20are%20frequently%20downregulated%20in%20colorectal%20cancer&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=CHIANG,%20YEUNPO&rft.date=2012-03-01&rft.volume=3&rft.issue=3&rft.spage=560&rft.epage=566&rft.pages=560-566&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2011.436&rft_dat=%3Cpubmed_cross%3E22969930%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-8f2805656407f9e56086f71334b030d25f94f7f8c10b0666c867dbcd85ded9113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/22969930&rfr_iscdi=true |